GlobeNewswire Inc | Feb 16, 2021 05:35PM EST

February 16, 2021

CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (GenMark or the Company), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Cowen 41st Annual Health Care Conference.

GenMarks management team is scheduled to present in a virtual setting on Monday, March 1st, 2021 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com

ABOUT GENMARKGenMark Diagnostics(NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMarks proprietary eSensor detection technology, GenMarks eSensor XT-8 and ePlex systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMarks ePlex: The True Sample-to-Answer Solution is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visitgenmarkdx.com

Investor Relations ContactLeigh Salvo(415) 937-5404ir@genmarkdx.com